PAR:ABVX

ABIVAX Société Anonyme Stock Insider Trading

Euronext Paris > Healthcare > Biotechnology

12.46€

-0.660 (-5.03%)

At Close: Jun 25, 2024

ABIVAX Société Anonyme Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 ABVX.PA shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About ABIVAX Société Anonyme

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral ... ABVX.PA Profile

Golden Star

Ticker	Date	Change	Price
ANGL	Jun 20	0.0350%	$28.57
BRK-A	Jun 20	0.575%	$617,249.90
EPD	Jun 18	2.90%	$28.30
USFD	Jun 18	4.33%	$53.14
UFPT	Jun 18	2.69%	$253.79
^DJI	Jun 18	1.48%	38,834.86 points
SARK	Jun 17	2.34%	$30.34
RGA	Jun 17	1.53%	$203.90
MA	Jun 17	1.68%	$448.11
BR	Jun 17	1.44%	$197.65

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In